pentobarbital will minimize the level or impact of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay away from coadministration. Potent or average CYP3A inducers might lower cobimetinib systemic exposure by >eighty% and cut down its efficacy.benzhydrocodone/acetaminophen and pentobarbital each improve sed